BioSpace News Archive

Allergan, an AbbVie (NYSE: ABBV) company, today announced that it will present new pooled analyses and post hoc results from the Phase 3 trials of AGN-190584 (pilocarpine HCl ophthalmic solution 1.25%), an investigational novel treatment for presbyopia, at Academy 2021, the annual meeting of the American Academy of Optometry, November 3-6.

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that the company will participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference taking place virtually October 28-29, 2021.

Metabolic syndrome constitutes a group of risk factors—including obesity, hyperglycemia, dyslipidemia, and hypertension—that increase the risk of cardiovascular and cerebrovascular diseases.

The commonly prescribed analgesic (pain killer) drug aspirin is also effective at preventing blood clots, with possibly lesser adverse effects.

Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (“Chemomab”), today announced that it will host a key opinion leader (KOL) live webinar featuring systemic sclerosis (SSc) expert Dr. Dinesh Khanna on Wednesday, November 3, 2021, at 10:00 am Eastern Time.

Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release third quarter 2021 financial results on Thursday, November 4, 2021, after the close of markets.

Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions announce their available services for GlaxoSmithKline’s infused medication sotrovimab.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.

Lucence, a precision oncology company using liquid biopsy to bring clarity to cancer care, and Yemaachi Biotech, a cancer research company based in Accra, Ghana, announced today that they are collaborating on a study to better characterize and understand the genomics of breast cancer in women of African descent.

Todos Medical, Ltd. today announced that its CEO Gerald Commissiong will be presenting a corporate overview at the Benzinga Global Small Cap Conference which is being held virtually on October 27-28, 2021.